TREA

79290136 - NOAELPLATIN

Follow

Information

  • Trademark
  • 79290136
  • Serial Number
    79290136
  • Registration Number
    6398898
  • Filing Date
    June 16, 2020
    5 years ago
  • Registration Date
    June 29, 2021
    4 years ago
  • Transaction Date
    June 03, 2022
    3 years ago
  • Status Date
    June 03, 2022
    3 years ago
  • Published for Opposition Date
    April 13, 2021
    5 years ago
  • Location Date
    May 19, 2021
    5 years ago
  • Status Code
    404
  • Current Location
    TMO LAW OFFICE 100 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    SEVERSON, JUSTIN
  • Attorney Docket Number
    696-0024
    Attorney Name
    Lenny R. Jiang
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NOAELPLATIN
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of pancreatic tumors; pharmaceutical agents for the treatment of disorders in sensory organs; thyroid and para-thyroid hormone preparations; medicinal tonics for the treatment of pancreatic tumors; oral contraceptive pills; antiemetics; local anesthetics; bronchodilating preparations; anti-cough drops; androgen preparations; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents for use in regulating metabolism; vaccines against flu; chilblain preparations; pharmaceutical preparations for headache; anesthetics; pharmaceutical for use in the treating disorders of the peripheral nervous system; pharmaceutical preparations for immunity adjustment; nutritive substances for microorganisms for medical purposes; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for treating disorders of the urogenital organs; vitamin preparations; pharmaceutical preparations for the treatment of bone diseases; anti-inflammatory and antipyretic preparations; pharmaceutical agents for treating disorders of the digestive organs; pharmaceutical preparations for the treatment of cardiovascular disorders; nervines; ophthalmic preparations; allergy medications; chemico-pharmaceutical preparations for the treatment of pancreatic disorders; medicines for the treatment of gastrointestinal diseases; mineral injection preparations featuring vitamin supplements for medical purposes; antioxidants for medical purposes; haematogen; pharmaceutical preparations for tumor treatment; multivitamin preparations; laxative suppositories; pharmaceutical preparations for use in the treatment of disorders of the central nervous system; pharmaceutical preparations for diagnosis of cancer; sedatives; analgesics; vaginal washes for medical purposes; pharmaceutical preparations for treating asthma; medicines for treating tooth pain; hemorrhoid preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; vaccines against pneumococcal infections; dermatological pharmaceutical products; contraceptive preparations; antihypertensives; anti-uric preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treatment of hemorrhoids; antibiotic preparations; antibiotics; anti-cancer preparations; anti-cancer treatment supplements; antidepressants; anticoagulants; antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; febrifuges; vasoconstrictors; hypoglycemic agents; blood solvent being preparations for treating blood disorders; pharmaceutical preparations for treating disorders of the respiratory organs; respiratory stimulant preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for treating respiratory diseases and asthma; mixed vitamin preparations; preparations for the treatment of burns; disinfectants for chemical toilets; chemotherapeutics; preparations for treatment of hepatitis; preparations for treating colds; preparations for the treatment of hyperlipidemia; preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of osteoporosis; preparations for the treatment of osteoporosis; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparations for treating halitosis; nausea treatment preparations; antiulcerants; pharmaceutical preparations for the treatment of musculoskeletal disorders; preparations for the treatment of muscle fatigue; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for the treatment of rhinitis; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; pharmaceutical preparations for the treatment of cancerous cells; medicines for treating intestinal disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for treating allergies; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; medicated preparations for the treatment of mouth disorders; transdermal patches for medical treatment of nausea; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of gout; drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements
Case File Event Statements
  • 3/20/2022 - 4 years ago
    30 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC
  • 3/20/2022 - 4 years ago
    29 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 11/23/2021 - 4 years ago
    28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 10/28/2021 - 4 years ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 10/28/2021 - 4 years ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/29/2021 - 4 years ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/3/2021 - 4 years ago
    24 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 7/12/2021 - 4 years ago
    23 - REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED Type: CORV
  • 6/29/2021 - 4 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/19/2021 - 5 years ago
    21 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 4/13/2021 - 5 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/13/2021 - 5 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/12/2021 - 5 years ago
    18 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 3/24/2021 - 5 years ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/24/2021 - 5 years ago
    16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 3/24/2021 - 5 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/9/2021 - 5 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/4/2021 - 5 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/4/2021 - 5 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/2/2021 - 5 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 12/1/2020 - 5 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/8/2020 - 5 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/21/2020 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/21/2020 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/24/2020 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/23/2020 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/18/2020 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/28/2020 - 5 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/24/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/23/2020 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR